CTI BioPharma
Manufacturing · United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
United StatesWebsite
www.pacifica-trial.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About CTI BioPharma
Swedish Orphan Biovitrum AB is conducting the PACIFICA clinical trial, a randomized, controlled phase 3 study focused on evaluating the efficacy of pacritinib in patients with various forms of myelofibrosis. The trial specifically targets individuals with primary myelofibrosis, post polycythemia vera myelofibrosis, or post essential thrombocythemia myelofibrosis who experience severe thrombocytopenia. The intended clients for this study are health care professionals involved in the treatment of these conditions. The trial compares pacritinib against a selection of physician's choice therapies, including corticosteroids and hydroxyurea.Explore more
Popular SearchesCTI BioPharma CorpSIC Code 28,283NAICS Code 32,325Show more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is CTI BioPharma your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Check if CTI BioPharma has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when CTI BioPharma launches new products
Funding: Get notified immidiatlly once CTI BioPharma has new funding data
Check out if CTI BioPharma is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at CTI BioPharma
CTI BioPharma, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on CTI BioPharma recently announced quarterly report
Click to see if CTI BioPharma had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Reach out to Masked Content who joined CTI BioPharma as Masked Content
Find more new buyers
Compare Similar Companies to CTI BioPharma
Compare insights from companies similar to CTI BioPharma, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
CTI BioPharma
<$5M
11-50
Private
-
-
N/A
Company Profile Activity
Activity Insights
CTI BioPharma is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
CTI BioPharma is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about CTI BioPharma.
CTI BioPharma Tech Stack
A closer look at the technologies used by CTI BioPharma
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding CTI BioPharma
Sign Up For FreeTo access detailed company insights
Swedish Orphan Biovitrum AB is conducting the PACIFICA clinical trial, a randomized, controlled phase 3 study focused on evaluating the efficacy of pacritinib in patients with various forms of myelofibrosis. The trial specifically targets individuals with primary myelofibrosis, post polycythemia vera myelofibrosis, or post essential thrombocythemia... Read More
